REALE, MARIA LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.269
EU - Europa 764
AS - Asia 472
SA - Sud America 18
OC - Oceania 13
AF - Africa 9
Totale 2.545
Nazione #
US - Stati Uniti d'America 1.248
IT - Italia 268
CN - Cina 152
IE - Irlanda 135
SE - Svezia 116
SG - Singapore 113
GB - Regno Unito 62
VN - Vietnam 53
UA - Ucraina 33
JP - Giappone 29
DE - Germania 26
HK - Hong Kong 26
FR - Francia 24
IN - India 21
CA - Canada 17
PL - Polonia 16
KR - Corea 15
BE - Belgio 13
ES - Italia 13
AU - Australia 12
JO - Giordania 12
IR - Iran 10
AT - Austria 8
TR - Turchia 8
CH - Svizzera 7
PK - Pakistan 7
RU - Federazione Russa 7
TW - Taiwan 7
FI - Finlandia 6
BR - Brasile 5
GR - Grecia 5
HR - Croazia 5
NL - Olanda 5
PE - Perù 5
CO - Colombia 4
EG - Egitto 4
RO - Romania 4
EC - Ecuador 3
ID - Indonesia 3
PS - Palestinian Territory 3
TN - Tunisia 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
MK - Macedonia 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
Totale 2.545
Città #
Chandler 237
Dublin 134
Fairfield 100
Singapore 78
Nyköping 66
Ashburn 55
Woodbridge 49
Turin 47
Torino 43
Medford 37
Seattle 36
Wilmington 35
Beijing 34
Cambridge 34
Houston 33
Princeton 30
Redwood City 28
Dong Ket 25
Ann Arbor 23
Hangzhou 22
New York 20
Central 17
Fremont 15
Milan 14
Dearborn 13
Jacksonville 13
Santa Clara 13
Amman 12
Pisa 12
Seoul 12
Hebei 10
Nanjing 10
San Diego 10
Boston 9
Tokyo 9
Piemonte 8
Rome 8
Vienna 8
Warsaw 8
Chengdu 7
London 7
Boardman 6
Karachi 6
Kraków 6
Brussels 5
Hefei 5
Helsinki 5
Jinan 5
Los Angeles 5
Manchester 5
Shijiazhuang 5
Taipei 5
Castellaneta 4
Central District 4
Dalmine 4
Kingston upon Thames 4
Medellín 4
Munich 4
Paris 4
Preston 4
Pune 4
San Jose 4
Shanghai 4
Tehran 4
Toronto 4
Vancouver 4
Washington 4
Adana 3
Amsterdam 3
Biella 3
Delhi 3
Falls Church 3
Guangzhou 3
Hoffman 3
Istanbul 3
Kulmbach 3
Mumbai 3
Namur 3
Norwalk 3
Parma 3
Ramallah 3
Redmond 3
River Edge 3
Rochester 3
San Francisco 3
Thai Nguyen 3
Verona 3
Wakagi 3
Zibo 3
Zurich 3
Bayonne 2
Bhilai 2
Bologna 2
Bolzano 2
Boquete 2
Brent 2
Buffalo 2
Bury 2
Cagliari 2
Cairo 2
Totale 1.588
Nome #
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma 212
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 171
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 158
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review 140
Quality of life in patients with lung cancer: the way forward 126
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients 110
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival 107
SELECTing adjuvant treatment in early stage epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer 103
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018 93
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit 91
Osimertinib-induced Cardiac Dysfunction in EGFRMutated Lung Cancer: A Case Series of Five Patients 86
LATITUDE and other coordinates in quality of life of prostate cancer patients 81
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave 72
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era 72
Clinical and molecular features of epidermal growth factor receptor (Egfr) mutation positive non‐small‐cell lung cancer (nsclc) patients treated with tyrosine kinase inhibitors (tkis): Predictive and prognostic role of co‐mutations 72
Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? 66
Dealing with NSCLC EGFR mutation testing and treatment: a comprehensive review with an Italian real-world perspective 64
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients 62
68 Ga-PSMA Uptake in Fibrous Dysplasia 57
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 57
Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: Are we actually ready? 57
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics 57
Repositioning PARP inhibitors in the treatment of thoracic malignancies 56
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease 53
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features 51
Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center 48
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 46
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon 46
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements 45
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer 40
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 39
Resistance to anaplastic lymphoma kinase inhibitors: Knowing the enemy is half the battle won 34
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center 26
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program 13
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 10
The KEY for chemo-immunotherapy combination: Taking NOTEs from squamous cell lung cancer 4
Totale 2.625
Categoria #
all - tutte 9.469
article - articoli 0
book - libri 0
conference - conferenze 252
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.721


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020175 0 0 4 14 10 20 23 18 28 22 20 16
2020/2021434 17 16 26 22 33 21 22 32 59 51 33 102
2021/2022605 46 33 37 27 36 28 41 40 21 66 144 86
2022/2023814 66 103 38 79 66 173 47 66 68 21 56 31
2023/2024437 69 58 20 54 17 48 8 25 10 40 50 38
2024/202593 22 71 0 0 0 0 0 0 0 0 0 0
Totale 2.625